Premium
Non‐Enzymatic Lysine Lactoylation of Glycolytic Enzymes
Author(s) -
GALLIGAN JAMES,
Gaffney Dominique O.,
Jennings Erin Q.,
Anderson Colin C,
Marentette John O.,
Shi Taoda,
Oxvig Anne-Mette Schou,
Streeter Matthew D.,
Johannsen Mogens,
Spiegel David A.,
Chapman Eli,
Roede James R
Publication year - 2020
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.2020.34.s1.02010
Subject(s) - methylglyoxal , glycolysis , biochemistry , enzyme , chemistry , lactoylglutathione lyase , proteome , proteomics , flux (metallurgy) , organic chemistry , gene
Post‐translational modifications (PTMs) regulate enzyme structure and function to expand the functional proteome. Many of these PTMs are derived from cellular metabolites and serve as feedback and feed‐forward mechanisms of regulation. We have identified a novel PTM that is derived from the glycolytic by‐product, methylglyoxal. This reactive metabolite is rapidly conjugated to glutathione via glyoxalase 1, generating lactoylglutathione (LGSH). LGSH is hydrolyzed by glyoxalase 2 (GLO2), cycling glutathione and generating D‐lactate. We have identified the non‐enzymatic acyl transfer of the lactate moiety from LGSH to protein Lys residues, generating a ‘LactoylLys’ modification on proteins. GLO2 knockout cells have elevated LGSH and consequently, a marked increase in LactoylLys. Using an alkyne‐tagged methylglyoxal analog, we show that these modifications are enriched on glycolytic enzymes and regulate glycolysis. Collectively, these data suggest a previously unexplored feedback mechanism that may serve to regulate glycolytic flux under hyperglycemic or Warburg‐like conditions. Support or Funding Information Financial support was provided by National Institutes of Health Grants (R01 ES027593 for J.R.R.), the SENS foundation (D.A.S.), the American Diabetes Association Pathway to Stop Diabetes Grant 1‐17‐VSN‐04 (D.A.S.), and the Velux Foundations (VELUX34148, A‐M.S.O). Mass spectrometry and proteomics data were acquired by the University of Arizona Analytical and Biological Mass Spectrometry Facility supported by NIH/NCI grant CA023074 to the University of Arizona Cancer Center, UA Research Development and Innovation Office, and by the BIO5 Institute of the University of Arizona.